« Zurück
Startseite /
RABBIT ANTI HUMAN PI3-KINASE p110 SUBUNIT DELTA (C-TERMINAL)

RABBIT ANTI HUMAN PI3-KINASE p110 SUBUNIT DELTA (C-TERMINAL)

ArtNr	18-783-313611
Hersteller	GENWAY
Menge	0.1 mg
Kategorie	Oncology Antibodies By Cell Type Blastoma Carcinoma Glioma Hematology Leukemia Lymphoma Myeloma Melanoma Sarcoma Cell Biology Cell Status Adenocarcinoma Mesothelioma Western Blot Autophagy Cardiovascular Research Proliferation Myocardial Infarction Primary Antibodies
Typ	Antibody
Applikationen	WB
Specific against	Human (Homo sapiens)
Host	Rabbit
ECLASS 10.1	32160702
ECLASS 11.0	32160702
UNSPSC	12352203
Alias	GWB-F26DE0
Similar products	18-783-313611
Lieferbar
Genway ID:	GWB-F26DE0
Specificity:	PI3-KINASE p110 SUBUNIT DELTA (C-TERMINAL)
Isotype:	Polyclonal IgG
Buffer Solution:	KHPO4 pH7. 4
Preservative Stabilisers:		0. 09% Sodium Azide (NaN3) 0. 1% Bovine Serum AlbuminApprox. Protein Concentrations: IgG concentration 1. 0mg/ml
Immunogen:	Synthetic peptide SWKTKVNWLAHNVSKDNRQ with added cysteine corresponding to amino acids 1026-1044 within the C-terminal region of human PI3-Kinase p110 subunit delta.
Specificity:	Specifically recognises an epitope within the C-terminal (CT) region of human PI3-kinase p110 subunit delta (Phosphatidylinositol-4 5-bisphosphate 3-kinase catalytic subunit delta) a member of the PI3/PI4-kinase family of lipid kinases implicated in the regulation of signal transduction during cell growth. PI3-kinase is a heterodimer consisting of a p85 regulatory subunit and a p110 catalytic subunit which itself is divided into isoforms p110alpha p110beta p110delta and p110gamma. Studies have shown that p110delta is predominantly restricted to leucocytes exhibits a broad phosphoinositide lipid substrate specificity and binds to Ras-GTP and p85.
Specificity:	Is reported as suitable for use in immunocytochemistry. Recommended Positive Controls: JURKAT CELL TOTAL PROTEIN LYSATERecommended Secondary Antibodies: Sheep Anti Rabbit IgGGoat Anti Rabbit IgG (Fc)Goat Anti Rabbit IgG (H/L)
Catalytic Activity:	ATP + 1-phosphatidyl-1D-myo-inositol 4 5-bisphosphate = ADP + 1-phosphatidyl-1D-myo-inositol 3 4 5-trisphosphate.
Pathway:	Phospholipid metabolism; phosphatidylinositol phosphate biosynthesis. Subunit structureHeterodimer of a p110 (catalytic) and a p85 (regulatory) subunit. Interacts with ERAS By similarity. Tissue specificityExpressed predominantly in leukocytes. Post-translational modificationAutophosphorylation on Ser-1039 results in the almost complete inactivation of the lipid kinase activity. Sequence similaritiesBelongs to the PI3/PI4-kinase family. Contains 1 PI3K/PI4K domain.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Arbeitsanleitung (Data Sheet) anfordern

Produkt-Datenblatt anfordern

Sicherheitsdatenblatt anfordern

Einfache Bestellung Periodische Bestellung

Menge: 0.1 mg

lieferbar

Lieferung vsl. bis 11.09.2025

Express-Lieferung: 7 Tage sparen

Vergleichen

Auf den Wunschzettel

Angebot anfordern